 |
Pro-Life Women's Health Care is Spreading throughout the World Recent Events in Poland, Costa Rica
PRESS RELEASE
(Omaha, Nebr.) The Creighton Model FertilityCare System and NaPro Technology are emerging in countries around the world as a source of hope in women's reproductive healthcare. Currently, these revolutionary methods are being used in 30 nations across the globe and on every continent but Antarctica.
The Creighton Model FertilityCare System and the new women's health science of NaProTechnology have been developed through a research and education effort coordinated and directed by Thomas W. Hilgers, MD, director of the Omaha-based Pope Paul VI Institute for the Study of Human Reproduction and clinical professor in the Department of Obstetrics and Gynecology, Creighton University School of Medicine.
"NaPro Technology is introduced to countries in a variety of ways," explained Dr. Hilgers, "Usually someone in the health profession is looking for better solutions for the problems they treat in women, they hear about what we are doing and it captures their interest and imagination. This was the case in Poland."
In May 2007, Dr. Hilgers was invited to speak at a medical meeting in Krakow, Poland and met Dr. Piotr Klimas who became the country's first FertilityCare medical consultant who has championed in the new women's health science of NaProTechnology.
Currently, there are 22 medical consultants and 48 FertilityCare practitioners in Poland. These numbers are expected to increase because in the fall of 2012, the Institute will take its entire education program to Warsaw to train more FertilityCare practitioners, FertilityCare medical consultants and European FertilityCare Educators, who will then arrange for additional practitioner training programs throughout Europe.
This past September, renowned neonatologist Janusz Gazinowski of the Polish Society for Perinatal Medicine invited Dr. Hilgers to address the issue of premature birth linked to IVF in a debate with the leading proponent of in vitro fertilization (IVF) at the organization's conference. An estimated 400 doctors, mostly obstetrician-gynecologists attended. It was the first time a debate between NaProTechnology and IVF took place in a professional venue.
According to Dr. Hilgers, in Poland, NaPro Technology has offset the effort to approve government funding of IVF. Dr. Hilgers recently returned from Costa Rica to present NaPro Technology as an alternative medical approach to infertility to government officials and an international conference. Costa Rica is the only country in South America that has not legalized IVF and Costa Rica is resisting efforts to force a change in the law.
"No matter what the reason for initial interest in the Creighton Model FertilityCare System and NaPro Technology, we have built a structure for the program that can be replicated successfully around the world to promote a culture of life in medicine."
Dr. Hilgers believes the program's expansion comes from a growing recognition that mainstream medicine and its reliance upon techniques such as birth control, sterilization, IVF and abortion, have not been effective in treating the underlying problems of women. NaPro Technology presents morally acceptable reproductive health services for the problems women face by diagnosing the underlyingproblems and treating them.
"It took seven years for a baby to be born after the introduction of IVF in Poland," Dr. Hilgers said, "and only a year-and-a-half for the first Polish NaPro baby to be born."
|
|
